Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC
PZ HTL SA

Molecular Pathways in the Hypothalamus Lead to Hypertension and Cardiovascular Disease

By BiotechDaily International staff writers
Posted on 23 Apr 2013
A recent paper linked overexpression of mTORC1 (mammalian target of rapamycin complex 1) activity in the hypothalamus to the development of cardiovascular diseases.

MTORC1 is a serine/threonine protein kinase of the phosphatidylinositol 3-kinase (PI3K) protein family that regulates cell growth, proliferation, motility, survival, protein synthesis, and transcription. In cancer cells, the mTOR pathway is deregulated and signals tumor cells to grow, divide, and metastasize.

Investigators at the University of Iowa (Iowa City, USA) showed in the April 2, 2013, issue of the journal Cell Metabolism that mTOR signaling in the hypothalamus was tied to the activity of the sympathetic nervous system and to cardiovascular function.

Modulation of mTORC1 signaling caused dramatic changes in sympathetic traffic, blood flow, and arterial pressure. The data also demonstrated the importance of hypothalamic mTORC1 signaling in transducing the sympathetic and cardiovascular actions of leptin, a hormone produced by fat cells that has been implicated in obesity-related hypertension. Leptin activated mTORC1 in a specific part of the hypothalamus causing increased nerve activity and a rise in blood pressure. These effects were blocked by inhibiting activation of mTORC1.

"Our study shows that when this protein [mTORC1] is either activated or inhibited in a very specific manner, it can cause dramatic changes in blood pressure,” said senior author Dr. Kamal Rahmouni, associate professor of pharmacology and internal medicine at the University of Iowa. "Given the importance of this protein for the control of blood pressure, any abnormality in its activity might explain the hypertension associated with certain conditions like obesity and cardiovascular disease."

"Cardiovascular diseases are the leading cause of death worldwide, and hypertension is a major cardiovascular risk factor," said Dr. Rahmouni. "Our study identifies the protein called mTORC1 in the hypothalamus as a key player in the control of blood pressure. Targeting mTORC1 pathways may, therefore, be a promising strategy for the management of cardiovascular risk factors."

Related Links:

University of Iowa



BIOSIGMA S.R.L.
SLAS - Society for Laboratory Automation and Screening
RANDOX LABORATORIES
comments powered by Disqus

Channels

Drug Discovery

view channel

Omega 3 Found to Improve Behavior in Children with ADHD

Supplements of the fatty acids omega 3 and 6 can help children and adolescents who have a specific kind of have attention deficit hyperactivity disorder (ADHD). Moreover, these findings indicate that a customized cognitive training program can improve problem behavior in children with ADHD. Statistics show that 3%–6%... Read more

Biochemistry

view channel

Blocking Enzyme Switch Turns Off Tumor Growth in T-Cell Acute Lymphoblastic Leukemia

Researchers recently reported that blocking the action of an enzyme “switch” needed to activate tumor growth is emerging as a practical strategy for treating T-cell acute lymphoblastic leukemia. An estimated 25% of the 500 US adolescents and young adults diagnosed yearly with this aggressive disease fail to respond to... Read more

Lab Technologies

view channel

e-Incubator Technology Provides Real-Time Imaging of Bioengineered Tissues in a Controlled Unit

A new e-incubator, an innovative miniature incubator that is compatible with magnetic resonance imaging (MRI), enables scientists to grow tissue-engineered constructs under a controlled setting and to study their growth and development in real time without risk of contamination or damage. Offering the potential to test... Read more

Business

view channel

Two Industry Partnerships Initiated to Fuel Neuroscience Research

Faster, more complex neural research is now attainable by combining technology from two research companies. Blackrock Microsystems, LLC (Salt Lake City, UT, USA), a developer of neuroscience research equipment, announced partnerships with two neuroscience research firms—PhenoSys, GmbH (Berlin, Germany) and NAN Instruments, Ltd.... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.